Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Cerebral palsy (CP) is a common childhood-onset disability associated with motor and
cognitive impairments, however most research is focused on motor outcomes. The aim of this
study is to determine the effects of Amantadine, a dopaminergic agonist, on cognitive
function in adolescents and adults with CP.